Indication

Diabetes mellitus with severe insulin resistance

Diabetes mellitus with severe insulin resistance is an endocrine and metabolic disorder characterized by persistent hyperglycemia arising from a profound impairment in target tissue responsiveness to insulin. Read more about Diabetes mellitus with severe insulin resistance

3 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Diabetes mellitus with severe insulin resistance therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Diabetes mellitus with severe insulin resistance preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Diabetes mellitus with severe insulin resistance.

Diabetes mellitus with severe insulin resistance is an endocrine and metabolic disorder characterized by persistent hyperglycemia arising from a profound impairment in target tissue responsiveness to insulin.

Primarily affecting metabolic tissues including skeletal muscle, adipose tissue, and the liver, this clinical state occurs either as an extreme presentation of type 2 diabetes—often exacerbated by profound obesity—or secondary to rare genetic or autoimmune conditions such as lipodystrophy syndromes, insulin receptor mutations, or anti-insulin receptor antibodies.

It is clinically defined by marked endogenous hyperinsulinemia or exceptionally high exogenous insulin requirements, commonly exceeding 2 units per kilogram per day or 200 units daily, and frequently manifests with severe acanthosis nigricans, pronounced dyslipidemia, and hepatic steatosis.

Personalize your experience

Follow Diabetes mellitus with severe insulin resistance and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it